Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

A patient with complete hair loss regrew all her hair using tofacitinib.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Dupilumab for skin problems might reactivate hair loss in some patients.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.